Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain Inhibitor Pyrvinium

[Image: see text] Pyrvinium was identified as the first small molecule inhibitor of the androgen receptor (AR) DNA-binding domain (DBD). It was also among the first small molecules shown to directly inhibit the activity of AR splice variants (ARVs), which has important clinical implications in the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Sumanta K., Tew, Ben Yi, Lim, Minyoung, Stankavich, Brittany, He, Miaoling, Pufall, Miles, Hu, Weidong, Chen, Yuan, Jones, Jeremy O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410682/
https://www.ncbi.nlm.nih.gov/pubmed/30873507
http://dx.doi.org/10.1021/acsomega.8b03205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410682/
https://www.ncbi.nlm.nih.gov/pubmed/30873507
http://dx.doi.org/10.1021/acsomega.8b03205

Ejemplares similares